CLINICAL_TRIALS
trial_result
· 2017-04-20
Clinical Trial Update: Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer [Phase 2]
Summary
A Phase 2 clinical trial evaluating lenalidomide in patients with advanced or unresectable kidney cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Cleveland Clinic | Conditions: Kidney Cancer | Phase 2 | Status: COMPLETED